Your browser doesn't support javascript.
loading
Prevalence, Risk factors, and Shedding of Human Herpes Virus-8 among Men Having Sex With Men Enrolled in a Pre-exposure Prophylaxis Study.
Gras, Julien; Helary, Marion; Carette, Diane; Minier, Marine; Salmona, Maud; Gabassi, Audrey; Saouzanet, Marine; Charreau, Isabelle; Meyer, Laurence; Molina, Jean-Michel; Delaugerre, Constance.
  • Gras J; Département des maladies infectieuses, AP-HP, Hôpital Saint Louis, Paris, France.
  • Helary M; Université de Paris, INSERM, U944, Centre National de la Recherche Scientifique Unité Mixte de Recherche 7212, Institut Universitaire d'Hématologie, Sorbonne Paris Cité, Université Paris Diderot, Hôpital Saint Louis, France.
  • Carette D; Service de Virologie, AP-HP, Hôpital Saint Louis, Paris, France.
  • Minier M; INSERM SC10-US19, Villejuif, France.
  • Salmona M; Service de Virologie, AP-HP, Hôpital Saint Louis, Paris, France.
  • Gabassi A; Service de Virologie, AP-HP, Hôpital Saint Louis, Paris, France.
  • Saouzanet M; INSERM U976 Team INSIGHT, Université Paris Cité, Paris, France.
  • Charreau I; Service de Virologie, AP-HP, Hôpital Saint Louis, Paris, France.
  • Meyer L; INSERM SC10-US19, Villejuif, France.
  • Molina JM; INSERM SC10-US19, Villejuif, France.
  • Delaugerre C; Université Paris-Sud, Université Paris-Saclay, France.
Clin Infect Dis ; 2023 Aug 25.
Article en En | MEDLINE | ID: mdl-37623814
ABSTRACT

BACKGROUND:

Seroprevalence and risk factors for Human Herpesvirus-8 (HHV-8) infection among HIV-negative men who have sex with men (MSM) on pre-exposure prophylaxis (PrEP) have not been well characterized. Our objectives were to assess the prevalence and incidence of HHV-8 infection in MSM enrolled on PrEP and assess viral shedding in seropositive participants.

METHODS:

The ANRS IPERGAY study enrolled 429 participants in France and Canada to evaluate oral PrEP for HIV-1 prevention. Stored sera samples at day 0 (D0) and last visit were tested for the detection of HHV-8 antibodies using an indirect immunofluorescence assay. Baseline characteristics were analyzed to identify risk factors associated with HHV-8 seropositivity. Among seropositive participants, HHV-8 DNA was quantified on available oral and anal swabs, and ORF-K1 typing performed on HHV-8 positive samples.

RESULTS:

One hundred participants were seropositive at D0 (prevalence of 24%, 95% Confidence Interval (95%CI) 20·0-28·4) and 18/329 seroconverted during the study (incidence rate of 2·66 per 100 person-years, 95%CI 1·57-4·20). Risk factors independently associated with baseline HHV-8 seropositivity included older age, high number of sexual partners, chemsex use and HSV-2 seropositivity. Among HHV-8 seropositive participants with available swab(s) for virological analysis, 37/115 (32%) displayed HHV-8 oral shedding, and 5/113 (4.4%) anal shedding at least once. Four patients had positive viral load before seroconversion.

CONCLUSION:

Prevalence and incidence of HHV-8 infection were high in HIV-negative PrEP users. Among seropositive participants, HHV-8 DNA is mainly detected in saliva, which may play a major role in viral transmission in this population.
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Etiology_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Etiology_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Idioma: En Año: 2023 Tipo del documento: Article